Ironwood Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with COUR Pharmaceuticals to Develop and Commercialize CNP-104 for the Treatment of Primary Bil
Go back to Ironwood Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with COUR Pharmaceuticals to Develop and Commercialize CNP-104 for the Treatment of Primary Bil| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $16.89 | |||
| Open | $3.82 | 52 Week Low | $7.35 | |||
| Day High | $3.82 | P/E | N/A | |||
| Day Low | $3.82 | EPS | $-2.35 | |||
| Volume | 1,222 | |||||
